Boundless Bio (BOLD) EPS (Diluted) (2023 - 2026)
Boundless Bio (BOLD) EPS (Diluted) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | 0.15 |
| 10 | Boundless Bio | 67.13 Mn | 67.13 Mn | - | -1.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.18 |
| Mar 31, 2026 | -3.64 |
| Dec 31, 2025 | -0.66 |
| Sep 30, 2025 | -3.82 |
| Jun 30, 2025 | -1.10 |
| Mar 31, 2025 | -0.71 |
| Dec 31, 2024 | -0.99 |
| Sep 30, 2024 | -0.75 |
| Jun 30, 2024 | -0.92 |
| Mar 31, 2024 | -40.00 |
| Dec 31, 2023 | -10.59 |
| Sep 30, 2023 | -11.30 |
| Jun 30, 2023 | -10.87 |
| Mar 31, 2023 | -10.48 |